Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Keynaut Epigenetics was a Spain-based private company that marketed epigenetics-themed consumer wellness and cosmetic products rather than regulated biopharmaceutical therapeutics. Public business-directory records identify the legal entity as Keynaut Epigenetics S.L., incorporated in 2020 in Terrassa, Barcelona, with business activity classified as online retail. Archived company materials and social channels describe coffee-based wellness products, cosmetics, and related lifestyle offerings, with operations including office, factory, laboratory, and warehouse functions in Barcelona. Based on the available evidence, Keynaut does not appear to be a drug-development biotech or pharma company with a disclosed therapeutic pipeline, clinical programs, or pharmaceutical partnerships. The company appears inactive as of the latest accessible business-directory records.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Keynaut Epigenetics.